EHA24: Danish LBA Shows that Oral Vitamin C Might Improve OS for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions
A Late-Breaking Abstract presented at EHA 2024 by Dr. Stine Ulrik Mikkelsen from Rigshospitalet, Denmark, shows that vitamin C supplementation has shown significant promise for improving survival in patients with low-risk myeloid malignancies and precursor conditions.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
